PLX106040

GSE116463: Inhibition of Hepatocellular Carcinoma Progression by Forced Metabolic Re-Programming

  • Organsim mouse
  • Type RNASEQ
  • Target gene
  • Project ARCHS4

Using two different mouse models of liver cancer, we have recently shown that the commonly observed metabolic switch from oxidative phosphorylation to glycolysis known as the Warburg effect is inevitably accompanied by a marked decrease in fatty acid oxidation (FAO) and an increase in the activity of pyruvate dehydrogenase, the enzyme linking glycolysis to the TCA cycle. We now show that the short-term implementation of either medium-chain or long-chain high fat diets (HFDs) just prior to the induction of c-Myc oncoprotein-driven hepatocellular carcinoma (HCC) nearly doubled survival. Mechanistically, HFDs forced tumors to become more reliant on fatty acids as an energy source, thus normalizing FAO and PDH activities. We extended these findings to eighteen different cancer cohorts patients by showing that some tumors with high ratios of FAO-related:glycolysis-related transcripts were associated with more favorable prognoses than those with low ratios. We also used t-SNE, a machine learning-based dimensionality reduction technique, to show in other human tumors that the expression patterns of transcripts encoding FAO-related proteins and enzymes involved in cholesterol biosynthesis were also predictive of survival. Collectively, our results support the idea that tumors which are either forced to utilize fatty acids as an energy source or those which are already predisposed to doing so show significantly less aggressive behaviors. These findings suggest that short-tern dietary manipulation, either alone or in conjunction with more traditional chemotherapeutic regimens, might be employed as a relatively non-toxic and inexpensive means of enhancing survival in certain cancer types. SOURCE: Edward,V,Prochownik (edward.prochownik@chp.edu) - Children’s Hospital of Pittsburgh of UPMC

View on GEOView in Pluto

Key Features

Enhance your research with our curated data sets and powerful platform features. Pluto Bio makes it simple to find and use the data you need.

Learn More

14K+ Published Experiments

Access an extensive range of curated bioinformatics data sets, including genomic, transcriptomic, and proteomic data.

Easy Data Import

Request imports from GEO or TCGA directly within Pluto Bio. Seamlessly integrate external data sets into your workflow.

Advanced Search Capabilities

Utilize powerful search tools to quickly find the data sets relevant to your research. Filter by type, disease, gene, and more.

Analyze and visualize data for this experiment

Use Pluto's intuitive interface to analyze and visualize data for this experiment. Pluto's platform is equipped with an API & SDKs, making it easy to integrate into your internal bioinformatics processes.

Read about post-pipeline analysis

View QC data and experiment metadata

View quality control data and experiment metadata for this experiment.

Request import of other GEO data

Request imports from GEO or TCGA directly within Pluto Bio.

Chat with our Scientific Insights team